Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Blinding in randomised trials: hiding who got what

Schulz, Kenneth F, Grimes, David A · 2002 · The Lancet

Abstract

Blinding embodies a rich history spanning over two centuries. Most researchers worldwide understand blinding terminology, but confusion lurks beyond a general comprehension. Terms such as single blind, double blind, and triple blind mean different things to different people. Moreover, many medical researchers confuse blinding with allocation concealment. Such confusion indicates misunderstandings of both. The term blinding refers to keeping trial participants, investigators (usually health-care providers), or assessors (those collecting outcome data) unaware of the assigned intervention, so that they will not be influenced by that knowledge. Blinding usually reduces differential assessment of outcomes (information bias), but can also improve compliance and retention of trial participants while reducing biased supplemental care or treatment (sometimes called co-intervention). Many investigators and readers naïvely consider a randomised trial as high quality simply because it is double blind, as if double-blinding is the sine qua non of a randomised controlled trial. Although double blinding (blinding investigators, participants, and outcome assessors) indicates a strong design, trials that are not double blinded should not automatically be deemed inferior. Rather than solely relying on terminology like double blinding, researchers should explicitly state who was blinded, and how. We recommend placing greater credence in results when investigators at least blind outcome assessm…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)07816-9

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. 1998, International conference on harmonisation: guidance on statistical principles for clinical trials, Fed Regist, 63, 49583
  2. Sackett, 1986, Tests for the blindness of randomized trials may not, Clin Res, 34, 711A

Cited by

See all 1,002

Metadata

Authors
Schulz, K. F., & Grimes, D. A.
Affiliations
Family Health International 360 (US)
Venue
The Lancet
Publisher
Elsevier BV
Published
2002-02
Volume
359
Issue
9307
Pages
696-700
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2002251042
Cited by
952
References
36
Citations by year
2026: 46 · 2025: 61 · 2024: 60 · 2023: 49 · 2022: 36 · 2021: 58 · 2020: 48 · 2019: 29 · 2018: 49 · 2017: 41 · 2016: 61 · 2015: 53 · 2014: 59 · 2013: 47 · 2012: 30
FWCI
23.61
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Keywords
blinding, randomized controlled trials, allocation concealment, double blinding, information bias, outcome assessment bias, trial reporting quality
MeSH terms
Double-Blind Method, Humans, Placebos, Epidemiologic Research Design, Randomized Controlled Trials as Topic, Single-Blind Method

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blinding in randomised trials: hiding who got what. https://app.cochat.ai/papers/10.1016/s0140-6736(02)07816-9
The paper
Schulz, K. F., & Grimes, D. A. (2002). Blinding in randomised trials: hiding who got what. The Lancet. https://doi.org/10.1016/s0140-6736(02)07816-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.